Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > 2-CHLORO-3-FLUOROISONICOTINIC ACID

2-CHLORO-3-FLUOROISONICOTINIC ACID

2-CHLORO-3-FLUOROISONICOTINIC ACID structure

2-CHLORO-3-FLUOROISONICOTINIC ACID 

structure
  • CAS No:

    628691-93-0

  • Formula:

    C6H3ClFNO2

  • Chemical Name:

    2-CHLORO-3-FLUOROISONICOTINIC ACID

  • Synonyms:

    2-Chloro-3-fluoroisonicotinic acid;2-Chloro-3-fluoropyridine-4-carboxylic acid;2-chloro-3-fluoro-4-carboxypyridine;922147-45-3;4-Pyridinecarboxylic acid, 2-chloro-3-fluoro-;2-chloro-3-fluoro-isonicotinic acid;2-chloro-3-fluoro-4-pyridinecarboxylic acid;2-chloro-3-fluoro-pyridine-4-carboxylic Acid;PubChem17055;ACMC-1BFBJ

  • Categories:

    Pharmaceutical Intermediates  >  Heterocyclic Compound

2-CHLORO-3-FLUOROISONICOTINIC ACID Basic Attributes

175.54

174.983627

2933399090

Characteristics

50.2

1.4

1.6±0.1 g/cm3

199 °C (dec.)

389.1°C at 760 mmHg

189.1±26.5 °C

1.563

Room temperature.

Safety Information

IRRITANT

NONH for all modes of transport

3

36/37/38

26-36

Xi

Irritant

P261-P305 + P351 + P338

H315-H319-H335

|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 44 companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

2-CHLORO-3-FLUOROISONICOTINIC ACID Use and Manufacturing

A mixture of lithium diisopropylamide (2M in heptane/ tetrahydrofuran/ethylbenzene-stabilised with magnesium bis- (diisopropylamide), 16. 7 ml) and tetrahydrofuran (30 ml) was cooled to [- 78°C] and [A PRE-COOLED (-78°C)] solution of 2-chloro-3-fluoropyridine (4.0 g, 30.4 mmol) in tetrahydrofuran (30 ml) was added dropwise over 20 min. After 3 h, carbon dioxide was bubbled through the cold reaction mixture for 20 min. The reaction was then warmed [TO-30°C] for 1 h then warmed [TO 0°C.] The mixture was quenched by the addition of water (75 [ML).] The aqueous phase was washed with diethyl ether (100 ml), then the pH of the solution adjusted to 2 by the addition of 2N hydrochloric acid. The resulting white precipitate was aged for 18 h then filtered and left to air- dry, which afforded [2-CHLORO-3-FLUOROISONICOTINIC] acid as a white solid (4.22 g, 79percent): 8H (360 MHz, DMSO) 7. 80 [(1H, ] dd, J 5 and 5), 8. 39 [(1H, ] d, J 5), 14.20 [(1H, ] s). [2-CHLORO-3-FLUOROISONICOTINIC] acid (3.30 g, 18.8 mmol) was suspended in thionyl chloride (40 ml) and heated under reflux for 2.5 h. The solvent was evaporated and the residue dried by means of azeotropic removal of water with toluene (100 ml) to afford a pale yellow oil. The oil was dissolved in dichloromethane (20 ml) and cooled to 0°C before methanol (2.42 g, 75.3 mmol) was added dropwise to the solution over 15 min. On complete addition the mixture was allowed to warm to ambient temperature and stirred for [18] h. The solvent was evaporated and the mixture partitioned between water (75 ml) and dichloromethane (100 ml). The aqueous phase was extracted further with dichloromethane (100 ml), the organic layers were combined, washed with brine (75 ml), dried over anhydrous sodium sulphate, filtered and evaporated to give 2-chloro-3- fluoroisonicotinic acid methyl ester (3.32 g, 93percent) as a pale yellow solid: [SN] (360 MHz, [CDCL3)] 3.99 (3H, s), 7.70 [(1H, ] dd, J 5 and 5), 8. 31 [(1H, ] d, J 5). [2-CHLORO-3-FLUOROISONICOTINIC] acid methyl ester (3.32 g, 17.5 mmol) was converted to 8-fluoroimidazo [[L, ] 2-a] pyridine-7-carboxylic acid methyl ester (1.4 g, 41percent) as described in Example 1. [8-FLUOROIMIDAZO] [1, 2-a] [PYRIDINE-7-CARBOXYLIC] acid methyl ester (0.19 g, 1.0 mmol) was brominated as described in Example [1, ] affording 3- [BROMO-8-FLUOROIMIDAZO] [1, 2-a] pyridine-7-carboxylic acid methyl ester (195 mg, 71percent): [8H] (360 MHz, CDCl3) 4.00 (3H, s), 7. 32 [(1H, ] t, [J 6.] 9), 7.43 (1H, dd, [J 7] and 6), 8. 19 [(1H, ] s), 8. 37 [(1H, ] d, [J 7).] 3-Bromo-8-fluoroimidazo [[L, ] 2-a] pyridine-7-carboxylic acid methyl ester (0.10 g, 0.37 mmol) and 4, [2APOS;-DIFLUORO-5APOS;- (5, ] 5-dimethyl- [1, 3, 2] [DIOXABORINAN-2-YL) BIPHENYL-2-CARBONITRILE] (0.15 g, 0.44 mmol) were coupled following the procedure in to afford 3- (2'-cyano-2, 4'- difluorobiphenyl-5-yl) -8-fluoroimidazo [1, 2-a] pyridine-7-carboxylic acid methyl ester (79 mg, 53percent) as a white solid: [6H] (400 MHz, CDCl3) 4.00 (3H, s), 7.35 [(1H, ] dd, J 7 and 7), 7.34-7. 46 (2H, [M), 7. 53-7.] 66 (4H, m), 7.85 (1H, [S), ] 8. 24 [(1H, ] [D, ] J [7)] ; m/z [(ES+)] 408 [(100percent, ] [MHZ+).]

Computed Properties

Molecular Weight:175.54
XLogP3:1.4
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:1
Exact Mass:174.9836342
Monoisotopic Mass:174.9836342
Topological Polar Surface Area:50.2
Heavy Atom Count:11
Complexity:167
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of 2-CHLORO-3-FLUOROISONICOTINIC ACID

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.